AG˹ٷ

STOCK TITAN

STANDEX REPORTS FISCAL FOURTH QUARTER AND FISCAL YEAR 2025 FINANCIAL RESULTS

Rhea-AI Impact
(Moderate)
Rhea-AI Sentiment
(Neutral)
Tags

Standex International (NYSE:SXI) reported strong Q4 FY25 financial results with sales increasing 23.2% year-over-year to $222.0 million. The company achieved a record adjusted operating margin of 20.6%, up 350 basis points YOY, and adjusted EPS grew 20.6% to $2.28.

Key highlights include debt reduction of $27 million in Q4, lowering the net debt to EBITDA ratio to 2.6x. Fast growth market sales reached $61 million, representing 28% of total sales. For FY26, Standex expects sales growth of over $100 million, plans to release 15+ new products, and projects fast growth market sales to exceed $265 million, growing approximately 45% year-on-year.

The Electronics segment, representing 52% of sales, showed particularly strong performance with 43.2% revenue growth to $115.2 million, while maintaining a healthy book-to-bill ratio of 1.03.

Standex International (NYSE:SXI) ha riportato risultati finanziari solidi nel quarto trimestre dell'anno fiscale 25, con vendite in aumento del 23,2% su base annua, raggiungendo 222,0 milioni di dollari. L'azienda ha raggiunto un margine operativo rettificato record del 20,6%, in crescita di 350 punti base rispetto all'anno precedente, e l'utile per azione rettificato è aumentato del 20,6%, arrivando a 2,28 dollari.

I punti salienti includono una riduzione del debito di 27 milioni di dollari nel quarto trimestre, che ha portato il rapporto debito netto/EBITDA a 2,6x. Le vendite nei mercati a rapida crescita hanno raggiunto i 61 milioni di dollari, rappresentando il 28% del totale delle vendite. Per l'anno fiscale 26, Standex prevede una crescita delle vendite di oltre 100 milioni di dollari, il lancio di oltre 15 nuovi prodotti e stima che le vendite nei mercati a rapida crescita supereranno i 265 milioni di dollari, con una crescita annua di circa il 45%.

Il segmento Elettronica, che rappresenta il 52% delle vendite, ha mostrato una performance particolarmente forte con una crescita dei ricavi del 43,2% a 115,2 milioni di dollari, mantenendo un solido rapporto book-to-bill di 1,03.

Standex International (NYSE:SXI) reportó sólidos resultados financieros en el cuarto trimestre del año fiscal 25, con ventas que aumentaron un 23,2% interanual hasta los 222,0 millones de dólares. La compañía alcanzó un margen operativo ajustado récord del 20,6%, un aumento de 350 puntos básicos respecto al año anterior, y las ganancias ajustadas por acción crecieron un 20,6% hasta 2,28 dólares.

Los aspectos destacados incluyen una reducción de deuda de 27 millones de dólares en el cuarto trimestre, disminuyendo la ratio deuda neta/EBITDA a 2,6x. Las ventas en mercados de rápido crecimiento alcanzaron los 61 millones de dólares, representando el 28% del total de ventas. Para el año fiscal 26, Standex espera un crecimiento de ventas superior a 100 millones de dólares, planea lanzar más de 15 nuevos productos y proyecta que las ventas en mercados de rápido crecimiento superarán los 265 millones de dólares, con un crecimiento anual aproximado del 45%.

El segmento de Electrónica, que representa el 52% de las ventas, mostró un desempeño especialmente fuerte con un crecimiento de ingresos del 43,2% hasta 115,2 millones de dólares, manteniendo una saludable relación book-to-bill de 1,03.

Standex International (NYSE:SXI)� 25회계연도 4분기 강력� 재무 실적� 보고했으�, 매출은 전년 대� 23.2% 증가하여 2� 2,200� 달러� 기록했습니다. 회사� 조정 영업이익률이 20.6%� 사상 최고치를 기록하며 전년 대� 350 베이시스 포인� 상승했고, 조정 주당순이익도 20.6% 증가하여 2.28달러� 달했습니�.

주요 내용으로� 4분기� 2,700� 달러� 부� 감축� 있었으며, 순부� 대� EBITDA 비율� 2.6배로 낮췄습니�. 빠르� 성장하는 시장 매출은 6,100� 달러� 달해 전체 매출� 28%� 차지했습니다. 26회계연도에는 매출� 1� 달러 이상 증가� 것으� 예상하며, 15� 이상� 신제� 출시� 계획하고 빠르� 성장하는 시장 매출은 2� 6,500� 달러� 넘어 전년 대� � 45% 성장� 것으� 전망합니�.

매출� 52%� 차지하는 전자 부문은 매출� 43.2% 증가하여 1� 1,520� 달러� 기록하며 특히 강한 실적� 보였�, 견고� 북투�(book-to-bill) 비율 1.03� 유지했습니다.

Standex International (NYSE:SXI) a annoncé de solides résultats financiers pour le quatrième trimestre de l'exercice 25, avec une augmentation des ventes de 23,2 % en glissement annuel, atteignant 222,0 millions de dollars. La société a enregistré une marge opérationnelle ajustée record de 20,6 %, en hausse de 350 points de base par rapport à l'année précédente, et le BPA ajusté a progressé de 20,6 % pour atteindre 2,28 dollars.

Parmi les faits marquants, une réduction de la dette de 27 millions de dollars au quatrième trimestre, abaissant le ratio dette nette/EBITDA à 2,6x. Les ventes sur les marchés à forte croissance ont atteint 61 millions de dollars, représentant 28 % du total des ventes. Pour l'exercice 26, Standex prévoit une croissance des ventes de plus de 100 millions de dollars, envisage de lancer plus de 15 nouveaux produits et projette que les ventes sur les marchés à forte croissance dépasseront 265 millions de dollars, soit une croissance annuelle d'environ 45 %.

Le segment Électronique, qui représente 52 % des ventes, a affiché une performance particulièrement solide avec une croissance du chiffre d'affaires de 43,2 % à 115,2 millions de dollars, tout en maintenant un ratio book-to-bill sain de 1,03.

Standex International (NYSE:SXI) meldete starke Finanzergebnisse für das vierte Quartal des Geschäftsjahres 25, mit einem Umsatzanstieg von 23,2 % im Jahresvergleich auf 222,0 Millionen US-Dollar. Das Unternehmen erreichte eine Rekord-Angepasste operative Marge von 20,6 %, ein Anstieg um 350 Basispunkte im Jahresvergleich, und der bereinigte Gewinn je Aktie stieg um 20,6 % auf 2,28 US-Dollar.

Zu den wichtigsten Highlights zählt eine Schuldenreduzierung von 27 Millionen US-Dollar im vierten Quartal, wodurch das Verhältnis von Nettoverschuldung zu EBITDA auf 2,6x gesenkt wurde. Die Umsätze in schnell wachsenden Märkten erreichten 61 Millionen US-Dollar und machten 28 % des Gesamtumsatzes aus. Für das Geschäftsjahr 26 erwartet Standex ein Umsatzwachstum von über 100 Millionen US-Dollar, plant die Einführung von über 15 neuen Produkten und prognostiziert, dass die Umsätze in schnell wachsenden Märkten 265 Millionen US-Dollar übersteigen und damit etwa 45 % im Jahresvergleich wachsen werden.

Der Elektronikbereich, der 52 % des Umsatzes ausmacht, zeigte mit einem Umsatzwachstum von 43,2 % auf 115,2 Millionen US-Dollar eine besonders starke Leistung und hielt ein gesundes Book-to-Bill-Verhältnis von 1,03 aufrecht.

Positive
  • Record Q4 adjusted operating margin of 20.6%, up 350 bps YOY
  • Sales increased 23.2% YOY to $222.0 million in Q4 FY25
  • Successful debt reduction of $27 million in Q4, improving net debt to EBITDA ratio to 2.6x
  • Fast growth market sales reached $61 million (28% of total sales)
  • Electronics segment revenue grew 43.2% YOY to $115.2 million
  • Strong book-to-bill ratio of 1.03 in Electronics segment
  • FY26 outlook projects over $100 million in revenue growth
Negative
  • GAAP Net Income from Continuing Operations declined 21.4% YOY to $15.5 million in Q4
  • GAAP Diluted EPS decreased 25.9% YOY to $1.23 in Q4
  • Scientific segment showed organic decline of 13.9% due to NIH funding cuts
  • Specialty Solutions revenue decreased 1.2% with lower operating income

Insights

Strong Q4 results with 23.2% revenue growth and record margins; debt reduction progress and positive FY26 outlook despite segment variations.

Standex delivered exceptional Q4 FY25 results with revenue climbing 23.2% year-over-year to $222.0 million, driven by acquisitions and organic growth in fast-growth markets. The most impressive metric is the record adjusted operating margin of 20.6%, expanding 350 basis points year-over-year and 120 basis points sequentially.

The Electronics segment was the standout performer, generating 52% of sales and 63% of adjusted operating income. Its revenue surged 43.2% with adjusted operating margin reaching an impressive 28.5%. The 1.03 book-to-bill ratio indicates continued demand strength, particularly in electrical grid markets served by the Amran/Narayan acquisition.

Notably, the company made significant progress in debt reduction, paying down $27 million in Q4, lowering its net debt to EBITDA ratio to 2.6x from 3.0x in the previous quarter. This demonstrates strong cash generation with free cash flow of $24.9 million, up 11.9% year-over-year.

The FY26 outlook is optimistic, projecting revenue growth exceeding $100 million with continued margin expansion. Fast-growth market sales are expected to grow ~45% and exceed $265 million. The company's focus on new product development (planning 15+ new products contributing ~300 bps of growth) and exposure to secular growth trends in electrical grid, EVs, renewable energy, and defense positions it well for sustained growth.

However, there are some areas of caution. The Scientific segment showed weakness with adjusted operating income declining 16.1% due to NIH funding cuts affecting academic customers. Specialty Solutions also experienced a 1.2% revenue decline and 17.2% drop in operating income. Additionally, projected Q1 FY26 sequential performance includes slightly lower revenue and adjusted operating margin in key segments due to seasonality and project timing.

Overall, Standex's transformation toward higher-margin, technology-focused markets is yielding results, with disciplined execution in pricing, productivity initiatives, and strategic acquisitions driving record profitability despite mixed segment performance.

  • In Q4 FY25, Sales Increased 23.2% YOY to $222.0 Million with Strong Momentum from New Products and Fast Growth Markets
  • Q4 FY25 GAAP Operating Margin of 15.6%; Record Adjusted Operating Margin of 20.6% - Up 120 bps Sequentially and 350 bps YOY
  • Paid Down $27 Million of Debt in Q4 FY25; Net Debt to EBITDA Ratio Lowered to 2.6x
  • Record Operating Performance in FY25:
    • GAAP Gross Margin of 39.9%; Record Adjusted Gross Margin of 41.7%, up 230bps YOY
    • GAAPEBIT Margin of 11.8%; Record Adjusted EBIT Margin of 19.1%, up 210 bps YOY
    • GAAP EPS of $4.65; Record Adjusted EPS of $7.98, up 5.8%۰
  • In FY26, Expect Sales to Increase >$100 Million; Plan to Release >15 New Products, Contributing ~300 bps of Growth; Fast Growth Market Sales Expected to Grow ~45% and Exceed $265 million

SALEM, N.H., July 31, 2025 /PRNewswire/ -- (NYSE: SXI) today reported financial results for the fourth quarter of fiscal year 2025 ended June 30, 2025.

Summary Financial Results - Total






($M except EPS and Dividends)

4Q25

4Q24

3Q25

/

Q/Q

Net Sales

$222.0

$180.2

$207.8

23.2%

6.9%

Operating Income � GAAP

$34.7

$27.1

$26.3

27.9%

32.3%

Operating Income � Adjusted

$45.8

$30.8

$40.3

48.7%

13.4%

Operating Margin % - GAAP

15.6%

15.1%

12.6%

+ 50 bps

+ 300 bps

Operating Margin % - Adjusted

20.6%

17.1%

19.4%

+ 350 bps

+ 120 bps

Net Income from Continuing Ops � GAAP

$15.5

$19.7

$22.8

-21.4%

-32.1%

Net Income from Continuing Ops � Adjusted

$27.5

$22.4

$23.5

22.8%

17.1%







EBITDA

$45.2

$33.9

$35.7

33.5%

26.8%

EBITDA margin

20.4%

18.8%

17.2%

+ 160 bps

+ 320 bps

Adjusted EBITDA

$51.6

$35.5

$45.3

45.5%

13.9%

Adjusted EBITDA margin

23.2%

19.7%

21.8%

+ 350 bps

+ 140 bps







Diluted EPS � GAAP

$1.23

$1.66

$1.81

-25.9%

-32.0%

Diluted EPS � Adjusted

$2.28

$1.89

$1.95

20.6%

16.9%

Dividends per Share

$0.32

$0.30

$0.32

6.7%

0.0%







Free Cash Flow

$24.9

$22.2

$3.5

11.9%

614.2%







Funded Debt to EBITDA per the Credit Facility

2.6x

0.0x

2.8x

NM

-7.1%

Net Debt to EBITDA

2.6x

0.0x

3.0x

NM

-13.3%

*Adjusted operating income, adjusted operating margin, and adjusted EPS for all periods now exclude amortization expense from acquired intangible assets.

Commenting on the quarter's results, President and Chief Executive Officer David Dunbarsaid, "We concluded our fiscal year with a very strong performance in the fourth quarter. Adjusted operating margin expanded 350 basis points year-on-year to a record 20.6% and adjusted earnings per share grew more than 20% to a record $2.28. These results reflect the continued evolution of our portfolio, accelerated by the acquisition of the Amran/Narayan Group in October 2024, and continued solid operational performance from core businesses. We paid down approximately $27 million of debt in the fiscal fourth quarter, and our net leverage ratio was reduced to 2.6x."

"Our fast growth market sales totaled $61 million or approximately 28% of total sales and have exceeded our expectations for the fiscal year. We remain confident about the Company's exposure to positive secular trends in electrical grid, electric and hybrid vehicles, renewable energy, commercialization of space, and defense, and weare reaffirming our long-term target for fast growth market sales of $340 million plus by fiscal year 2028. In addition, we launched three additional new products in the fiscal fourth quarter totaling 16 in fiscal year 2025, delivering 2.5% of incremental sales."

"Our acquisitions continue to perform well, and we are investing towards their future growth. Within Amran/Narayan, we expanded capacity in Houston and India and have begun commissioning our greenfield site in Croatia with shipments to begin within the next four months."

"Following record profitability in fiscal year 2024, we delivered several new records in fiscal year 2025 in adjusted gross margin, adjusted operating income, adjusted operating margin, and adjusted earnings per share. We remain optimistic about our long-term operating margin potential as we leverage organic growth, driven by our fast growth end markets and higher sales contribution from new products."

"Our regional presence, strong customer relationships, and our disciplined approach to pricing and productivity actions position us well to manage through the fluid global trade and economic environment. We plan to continue to invest in our key strategic growth priorities, while closely managing our cost structure, driving productivity and pricing actions and seeking alternate sources of supply. We remain on track to achieve our long-term financial targets by fiscal 2028 and remain confident in our ability to pay down debt to optimize our capital structure and be positioned to seize any future opportunities."

Fiscal First Quarter 2026 Outlook

In fiscal first quarter 2026, on a year-on-year basis, the Company expects significantly higher revenue comprised of the contribution from recent acquisitions and low-single-digit organic growth, along with significant adjusted operating margin expansion. On a sequential basis,the Company expects slightly lower revenue, as contribution from recent acquisitions, higher sales into fast growth end markets, and realization of pricing initiatives are more than offset by project timing in Engineering Technologies and the impact of seasonality in Europe within Electronics and Engraving. The Company expects slightly lower adjusted operating margin sequentially due to lower sales and less favorable product mix.

Fiscal Year 2026 Outlook

In fiscal year 2026, barring any unforeseen economic, global trade, or tariffs related disruptions, the Company expects revenue to grow by over $100 million and continued adjusted operating margin expansion, primarily driven by mid-to-high-single-digit organic growth in Electronics, double-digit organic growth in Engineering Technologies, and the contribution from recent acquisitions.The Company plans to release over fifteen new products that it expects will contribute approximately 300 bps of incremental growth. Sales from fast growth markets are expected to grow approximately 45% year-on-year and exceed $265 million. In fiscal year 2026, the Company is on track to further reduce its net debt to EBITDA ratio, positioning the Company well to fund future organic and inorganic opportunities.

Fourth Quarter Segment Operating Performance

Electronics (52% of sales; 63% of segment adjusted operating income)


4Q25

4Q24

% Change

Electronics ($M)




Revenue

115.2

80.4

43.2%

GAAP Operating Income

28.0

16.1

73.5%

GAAP Operating Margin %

24.3

20.1


Adjusted Operating Income*

32.9

17.8

84.7%

Adjusted Operating Margin %*

28.5

22.1



* Excludes the amortization of acquired backlog, the step-up of inventory to fair value, and acquired intangible assets; Q4 FY24 restated to exclude the amortization of acquired intangible assets

Revenue increased approximately $34.8 million or 43.2% year-on-year, reflecting a 41.0% benefit from acquisitions, organic growth of 0.3% and a 1.9% benefit from foreign currency. Adjusted operating income increased approximately $15.1 million or 84.7% year-on-year due to the contribution from the Amran/Narayan Group acquisition, pricing and productivity initiatives, and product mix.

The segment had a book-to-bill ratio of approximately 1.03 in the fiscal fourth quarter, with orders of approximately $118 million, an increase of approximately $10 million sequentially. Orders in Electronics' core business were up sequentially with a continued increase in demand in the electrical grid end market served by Amran/Narayan Group.

In fiscal first quarter 2026, on a sequential basis, the Company expects slightly lower revenue, reflecting the contribution from the Amran/Narayan Group acquisition, higher sales into fast growth end markets, and price realization, more than offset by the impact of seasonality in Europe. The Company expects slightly lower adjusted operating margin, primarily driven by product mix and continued strategic growth investments.

Engineering Technologies (14% of sales; 11% of segment adjusted operating income)


4Q25

4Q24

% Change

Engineering Technologies ($M)




Revenue

32.0

25.3

26.8%

GAAP Operating Income

4.3

5.3

-18.3%

GAAP Operating Margin %

13.5

20.9


Adjusted Operating Income*

5.9

5.3

11.8%

Adjusted Operating Margin %*

18.4

20.9



* Excludes the amortization of acquired backlog, the step-up of inventory to fair value, and acquired intangible assets

Revenue increased approximately $6.8 million or 26.8% year-on-year reflecting a 25.0% benefit from the McStarlite acquisition, organic growth of 0.9%, and a foreign currency benefit of 0.9%. Organic growth was primarily driven by growth in sales from new products. Adjusted operating income increased approximately $0.6 million or 11.8% year-on-year reflecting the contribution from the recent acquisition and higher volume.

In fiscal first quarter 2026, on a sequential basis, the Company expects slightly lower revenue and adjusted operating margin due to project timing.

Scientific(8% of sales; 8% of segment adjusted operating income)


4Q25

4Q24

% Change

Scientific ($M)




Revenue

17.9

17.5

2.3%

GAAP Operating Income

4.1

4.9

-16.6%

GAAP Operating Margin %

22.9

28.1


Adjusted Operating Income*

4.3

5.2

-16.1%

Adjusted Operating Margin %*

24.3

29.6



* Excludes the amortization of acquired intangible assets; Q4 FY24 restated to exclude the amortization of acquired intangible assets

Revenue increased approximately $0.4 million or 2.3% year-on-year reflecting a 16.1% benefit from the Custom Biogenic Systems acquisition, mostly offset by an organic decline of 13.9% from lower demand at academic and research institutions that were impacted by NIH funding cuts. Adjusted operating income decreased approximately $0.8 million or 16.1% year-on-year due to organic decline partially offset by contribution from the acquisition.

In fiscal first quarter 2026, on a sequential basis, the Company expects slightly higher revenue and similar adjusted operating margin.

Engraving (15% of sales; 10% of segment adjusted operating income)


4Q25

4Q24

% Change

Engraving ($M)




Revenue

33.0

32.7

0.6%

GAAP Operating Income

4.6

3.9

17.8%

GAAP Operating Margin %

14.1

12.0


Adjusted Operating Income*

5.0

4.4

14.9%

Adjusted Operating Margin %*

15.2

13.3







* Excludes the amortization of acquired intangible assets; Q4 FY24 restated to exclude the amortization of acquired intangible assets

Revenue increased approximately $0.2 million or 0.6% year-on-year reflecting a foreign currency benefit of 1.2%, partially offset by a 0.6% organic decline, primarily due to continued softness in North America from delays in new platform rollouts. Adjusted operating income increased approximately $0.6 million or 14.9% year-on-year due to the realization of previously announced productivity initiatives and restructuring actions.

In fiscal first quarter 2026, on a sequential basis, the Company expects similar revenue and slightly higher adjusted operating margin due to seasonality affecting Europe, offset by slightly improved demand in North America and Asia, and realization of previously announced restructuring actions. In the fiscal first quarter, the Company secured a source award from a major OEM in North America to supply soft trim parts for a calendar year 2026 program.

Specialty Solutions(11% of sales; 8% of segment adjusted operating income)


4Q25

4Q24

% Change

Specialty Solutions ($M)




Revenue

23.9

24.2

-1.2%

Operating Income

4.5

5.4

-17.2%

Operating Margin %

18.6

22.2


Specialty Solutions revenue decreased approximately $0.3 million or 1.2% year-on-year, reflecting general market softness in the Display Merchandising business and in the Hydraulics business. Operating income decreased approximately $0.9 million or 17.2% year-on-year due to lower volume.

In fiscal first quarter 2026, on a sequential basis, the Company expects similar revenue and slightly higher operating margin.

Capital Allocation

  • Interest: In fiscal first quarter 2026, the Company expects interest expense to be approximately $9 million.

  • Share Repurchase: During the fiscal fourth quarter of 2025, the Company didn't repurchase shares. There was approximately $28 million remaining on the Company's current share repurchase authorization at the end of the fiscal fourth quarter 2025.

  • Capital Expenditures: In fiscal fourth quarter 2025, the Company's capital expenditures were $8.6 million compared to $6.5 million in the fiscal fourth quarter of 2024. The Company expects fiscal year 2026 capital expenditures between $33 million and $38 million. Capital expenditures were $28.3 million in fiscal year 2025.

  • پԻ:On July 24, 2025, the Company declared a quarterly cash dividend of $0.32 per share, an approximately 6.7% year-on-year increase. The dividend is payable August 22, 2025, to shareholders of record on August 8, 2025.

Balance Sheet and Cash Flow Highlights

  • Net Debt:Standex had net (cash) debt of $448.0 million on June 30, 2025, compared to ($5.3) million at the end of fiscal fourth quarter 2024. Net (cash) debt for the fourth quarter of 2025 consisted primarily of long-term debt of $552.5 million and cash and equivalents of $104.5 million.
  • Cash Flow: Net cash provided by continuing operating activities for the three months ended June 30, 2025, was$33.4 million compared to $28.7 millionin the prior year's quarter. Free cash flow after capital expenditures was$24.9 millioncompared to free cash flow after capital expenditures of$22.2 millionin the fiscal fourth quarter of 2024.

Conference Call Details

Standex will host a conference call for investors tomorrow, August 1, 2025, at 8:30 a.m. ET. On the call, David Dunbar, President, and CEO, and Ademir Sarcevic, CFO, will review the Company's financial results and business and operating highlights. Investors interested in listening to the webcast and viewing the slide presentation should log on to the "Investors" section of Standex's website under the subheading, "Events and Presentations," located at .

A replay of the webcast will also be available on the Company's website shortly after the conclusion of the presentation online through August 1, 2026. To listen to the teleconference playback, please dial in the U.S. (888) 660-6345or (646) 517-4150 internationally; the passcode is 81307#. The audio playback via phone will be available through August 8, 2025. The webcast replay can be accessed in the "Investor Relations" section of the Company's website, located at .

Use of Non-GAAP Financial Measures

In addition to the financial measures prepared in accordance with generally accepted accounting principles ("GAAP"), the Company uses certain non-GAAP financial measures, including non-GAAP adjusted income from operations, non-GAAP adjusted net income from continuing operations, free operating cash flow, EBITDA (earnings before interest, taxes, depreciation and amortization) adjusted EBITDA, adjusted EBITDA to net debt, and adjusted earnings per share. The attached financial tables reconcile non-GAAP measures used in this press release to the most directly comparable GAAP measures. The Company believes that the use of non-GAAP measures which exclude the impact of restructuring charges, purchase accounting, amortization from acquired intangible assets, insurance recoveries, discrete tax events, gain or loss on sale of a business unit, acquisition costs, and litigation costs help investors to obtain a better understanding of our operating results and prospects, consistent with how management measures and forecasts the Company's performance, especially when comparing such results to previous periods. An understanding of the impact in a particular quarter of specific restructuring costs, acquisition expenses, or other gains and losses, on net income (absolute as well as on a per-share basis), operating income or EBITDA can give management and investors additional insight into core financial performance, especially when compared to quarters in which such items had a greater or lesser effect, or no effect. Non-GAAP measures should be considered in addition to, and not as a replacement for, the corresponding GAAP measures, and may not be comparable to similarly titled measures reported by other companies.

About Standex

Standex International Corporationis a multi-industry manufacturer in five broad business segments: Electronics, Engineering Technologies, Scientific, Engraving, and Specialty Solutions with operations in the United States, Europe, Canada, Japan, Singapore, Mexico, Turkey, India, and China. For additional information, visit the Company's website at .

Forward-Looking Statements

Statements contained in this Press Release that are not based on historical facts are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by the use of forward-looking terminology such as "should,""could,""may,""will,""expect,""believe,""estimate,""anticipate,""intend,""continue," or similar terms or variations of those terms or the negative of those terms. There are many factors that affect the Company's business and the results of its operations and that may cause the actual results of operations in future periods to differ materially from those currently expected or anticipated.These factors include, but are not limited to: the impact of pandemics and other global crises or catastrophic events on employees, our supply chain, and the demand for our products and services around the world; materially adverse or unanticipated legal judgments, fines, penalties or settlements; conditions in the financial and banking markets, including fluctuations in exchange rates and the inability to repatriate foreign cash; domestic and international economic conditions, including the impact, length and degree of economic downturns on the customers and markets we serve and more specifically conditions in the electrical grid, automotive, construction, aerospace, defense, transportation, food service equipment, consumer appliance, energy, oil and gas and general industrial markets; lower-cost competition; the relative mix of products which impact margins and operating efficiencies in certain of our businesses; the impact of higher raw material and component costs, particularly steel, certain materials used in electronics parts, petroleum based products, and refrigeration components; the impact of higher transportation and logistics costs, especially with respect to transportation of goods from Asia; the impact of inflation on the costs of providing our products and services; an inability to realize the expected cost savings from restructuring activities including effective completion of plant consolidations, cost reduction efforts including procurement savings and productivity enhancements, capital management improvements, strategic capital expenditures, and the implementation of lean enterprise manufacturing techniques; the potential for losses associated with the exit from or divestiture of businesses that are no longer strategic or no longer meet our growth and return expectations; the inability to achieve the savings expected from global sourcing of raw materials and diversification efforts in emerging markets; the impact on cost structure and on economic conditions as a result of actual and threatened increases in trade tariffs; the inability to attain expected benefits from acquisitions and the inability to effectively consummate and integrate such acquisitions and achieve synergies envisioned by the Company; increased costs from acquisitions to improve and coordinate managerial, operational, financial, and administrative systems, including internal controls over financial reporting and compliance with the Sarbanes-Oxley Act of 2002, and other costs related to such systems in connection with acquired businesses; market acceptance of our products; our ability to design, introduce and sell new products and related product components; the ability to redesign certain of our products to continue meeting evolving regulatory requirements; the impact of delays initiated by our customers; our ability to increase manufacturing production to meet demand including as a result of labor shortages; the impact on our operations of any successful cybersecurity attacks; and potential changes to future pension funding requirements. For a more comprehensive discussion of these and other factors, see the "Risk Factors" section of the Company's most recent annual report on Form 10-K filed with the SEC and available on the Company's website. In addition, any forward-looking statements represent management's estimates only as of the day made and should not be relied upon as representing management's estimates as of any subsequent date. While the Company may elect to update forward-looking statements at some point in the future, the Company and management specifically disclaim any obligation to do so, even if management's estimates change.

Standex International Corporation

Consolidated Statement of Operations

(unaudited)

















Three Months Ended



Year Ended




June 30,



June 30,

(In thousands, except per share data)



2025



2024



2025



2024














Net sales


$

222,049



180,194


$

790,107


$

720,635

Cost of sales



130,751



110,781



474,859



438,634

Gross profit



91,298



69,413



315,248



282,001














Selling, general and administrative expenses



47,954



38,949



178,750



161,415

(Gain) loss on sale of business



-



-



-



(274)

Restructuring costs



2,920



903



6,903



8,206

Amortization of acquired intangible assets



4,647



2,025



14,612



8,184

Acquisition related costs



1,042



389



21,434



2,622

Other operating (income) expense, net



-



-



-



110














Income from operations



34,734



27,147



93,549



101,738














Interest expense



9,016



1,300



23,931



4,544

Other non-operating (income) expense, net



(364)



266



808



2,071

Total



8,652



1,566



24,739



6,615














Income from continuing operations before income taxes



26,082



25,581



68,810



95,123

Provision for income taxes



10,609



5,893



11,084



21,532

Net income from continuing operations



15,473



19,688



57,726



73,591














Income (loss) from discontinued operations, net of tax



13



(97)



(42)



(517)














Net income



15,486



19,591



57,684



73,074

Less: net income attributable to redeemable noncontrolling interest



660



-



1,924



-

Net income attributable to Standex International


$

14,826


$

19,591


$

55,760


$

73,074














Basic earnings per share:













Income (loss) from discontinued operations



-



-



-



(0.04)

Total income (loss) attributable to Standex International


$

1.23


$

1.67


$

4.68


$

6.22














Diluted earnings per share:













Income (loss) from discontinued operations



-



(0.01)



-



(0.04)

Total income (loss) attributable to Standex International


$

1.23


$

1.65


$

4.64


$

6.14














Average Shares Outstanding













Basic



11,990



11,761



11,926



11,763

Diluted



12,076



11,892



12,016



11,904

Standex International Corporation

Condensed Consolidated Balance Sheets

(unaudited)











June 30,



June 30,

(In thousands)



2025



2024








ASSETS







Current assets:







Cash and cash equivalents


$

104,542



154,203

Accounts receivable, net



172,702



121,365

Inventories



129,994



87,106

Prepaid expenses and other current assets



73,641



67,421

Total current assets



480,879



430,095








Property, plant, equipment, net



160,364



134,963

Intangible assets, net



225,757



78,673

Goodwill



610,338



281,283

Deferred tax asset



11,971



17,450

Operating lease right-of-use asset



47,998



37,078

Other non-current assets



29,573



25,515

Total non-current assets



1,086,001



574,962








Total assets


$

1,566,880


$

1,005,057








LIABILITIES, REDEEMABLE NONCONTROLLING INTEREST AND STOCKHOLDERS' EQUITY










Current liabilities:







Accounts payable


$

88,001



63,364

Accrued liabilities



63,204



56,698

Income taxes payable



15,770



7,503

Total current liabilities



166,975



127,565








Long-term debt



552,515



148,876

Operating lease long-term liabilities



40,057



30,725

Accrued pension and other non-current liabilities



67,743



76,388

Total non-current liabilities



660,315



255,989








Redeemable non-controlling interest



27,913



-








Stockholders' equity:







Common stock



41,976



41,976

Additional paid-in capital



136,082



106,193

Retained earnings



1,126,851



1,086,277

Accumulated other comprehensive loss



(164,765)



(182,956)

Treasury shares



(428,467)



(429,987)

Total stockholders' equity



711,677



621,503








Total liabilities, redeemable noncontrolling interest and stockholders' equity


$

1,566,880


$

1,005,057

Standex International Corporation and Subsidiaries

Statements of Consolidated Cash Flows

(unaudited)




Year Ended




June 30,

(In thousands)



2025



2024








Cash flows from operating activities







Net income (loss)


$

57,684


$

73,074

Income (loss) from discontinued operations



(42)



(517)

Income from continuing operations



57,726



73,591








Adjustments to reconcile net income to net cash provided by operating activities:







Depreciation and amortization



35,438



28,140

Stock-based compensation



8,691



9,811

Non-cash portion of restructuring charge



10



151

(Gain) loss on sale of business



-



(274)

Contributions to defined benefit plans



(7,796)



(10,238)

Net changes in operating assets and liabilities



(24,421)



(7,835)

Net cash provided by (used in) operating activities - continuing operations



69,648



93,346

Net cash provided by (used in) discontinued operations



(52)



(690)

Net cash provided by (used in) operating activities



69,596



92,656

Cash flows from investing activities







Expenditures for property, plant and equipment



(28,343)



(20,298)

Expenditures for acquisitions, net of cash acquired



(478,890)



(48,835)

Proceeds from the sale of business



-



7,774

Other investing activities



3,800



(270)

Net cash provided by (used in) investing activities - continuing operations



(503,433)



(61,629)

Net cash provided by (used in) investing activities - discontinued operations



-



-

Net cash provided by (used in) investing activities



(503,433)



(61,629)

Cash flows from financing activities







Proceeds from borrowings



792,313



-

Payments of debt



(389,109)



(25,000)

Cash dividend paid



(15,033)



(13,902)

Purchase of treasury stock and other



(9,906)



(31,824)

Activity under share-based payment plans



2,226



1,525

Net cash (used in) financing activities



380,491



(69,201)

Effect of exchange rate changes on cash and cash equivalents



3,686



(3,329)

Net change in cash and cash equivalents



(49,660)



(41,503)

Cash and cash equivalents at beginning of period



154,203



195,706

Cash and cash equivalents at end of period


$

104,543


$

154,203

Standex International Corporation

Selected Segment Data

(unaudited)

















Three Months Ended



Year Ended




June 30,



June 30,

(In thousands)



2025



2024



2025



2024

Net Sales













Electronics


$

115,192


$

80,417


$

400,130


$

321,956

Engineering Technologies



32,040



25,271



102,595



83,476

Scientific



17,918



17,521



72,380



68,931

Engraving



32,958



32,749



128,360



150,685

Specialty Solutions



23,941



24,236



86,642



95,587

Total


$

222,049


$

180,194


$

790,107


$

720,635














Income from operations













Electronics


$

28,009


$

16,146


$

87,927


$

64,030

Engineering Technologies



4,308



5,270



15,428



15,216

Scientific



4,108



4,926



17,470



19,000

Engraving



4,643



3,943



17,647



26,708

Specialty Solutions



4,453



5,381



14,841



19,631

Gain (loss) on sale of business



-



-



-



274

Restructuring



(2,920)



(903)



(6,903)



(8,206)

Acquisition related costs



(1,042)



(389)



(21,434)



(2,622)

Corporate



(6,825)



(7,227)



(31,427)



(32,183)

Other operating income (expense), net



-



-



-



(110)

Total


$

34,734


$

27,147


$

93,549


$

101,738

Standex International Corporation

Reconciliation of GAAP to Non-GAAP Financial Measures

(unaudited)























Three Months Ended





Year Ended







June 30,





June 30,



(In thousands, except percentages)



2025



2024


% Change



2025



2024


% Change

Adjusted income from operations and adjusted net income from continuing
operations:
















Net Sales


$

222,049


$

180,194


23.2%


$

790,107


$

720,635


9.6%

Income from operations, as reported


$

34,734


$

27,147


27.9%


$

93,549


$

101,738


-8.0%


Income from operations margin



15.6%



15.1%





11.8%



14.1%



Adjustments:


















Restructuring charges



2,920



903





6,903



8,206




Acquisition-related costs



1,042



389





21,434



2,622




Amortization of acquired intangible assets



4,647



2,025





14,612



8,184




(Gain) loss on sale of business



-



-





-



(274)




Environmental remediation



-



-





-



110




Purchase accounting expenses



2,407



305





14,083



1,768



Adjusted income from operations


$

45,751


$

30,769


48.7%


$

150,581


$

122,354


23.1%


Adjusted income from operations margin



20.6%



17.1%





19.1%



17.0%




Interest and other income (expense), net



(8,652)



(1,566)





(24,739)



(6,615)




Foreign currency related (gain) loss on acquisition and divestiture activities



-



-





554



309




Provision for income taxes



(10,609)



(5,893)





(11,084)



(21,532)




Discrete and other tax items



3,502



-





(5,444)



100




Tax impact of above adjustments



(1,808)



(869)





(12,113)



(4,817)



Net income from continuing operations, as adjusted



28,183



22,441


25.6%



97,755



89,799


8.9%


Less: net income attributable to redeemable noncontrolling interest



660



-





1,924



-



Net income attributable to Standex International, as adjusted


$

27,523


$

22,441


22.6%


$

95,831


$

89,799


6.7%



















EBITDA and Adjusted EBITDA:

















Net income (loss) from continuing operations, as reported


$

15,473


$

19,688


-21.4%


$

57,726


$

73,591


-21.6%


Net income from continuing operations margin



7.0%



10.9%





7.3%



10.2%



Add back:


















Provision for income taxes



10,609



5,893





11,084



21,532




Interest expense



9,016



1,300





23,931



4,544




Depreciation and amortization



10,128



6,994





35,438



28,140



EBITDA


$

45,226


$

33,875


33.5%


$

128,179


$

127,807


0.3%


EBITDA Margin



20.4%



18.8%





16.2%



17.7%



Adjustments:


















Restructuring charges



2,920



903





6,903



8,206




Acquisition-related costs



1,042



389





21,434



2,622




(Gain) loss on sale of business



-



-





-



(274)




Foreign currency related (gain) loss on acquisition and divestiture activities



-



-





-



309




Environmental remediation



-



-





-



110




Purchase accounting expenses



2,407



305





14,083



1,768



Adjusted EBITDA


$

51,596


$

35,472


45.5%


$

170,599


$

140,548


21.4%





23.2%



19.7%





21.6%



19.5%





















Free operating cash flow:

















Net cash provided by operating activities - continuing operations, as reported


$

33,435


$

28,737




$

69,648


$

93,346



Less: Capital expenditures



(8,581)



(6,533)





(28,343)



(20,298)



Free cash flow from continuing operations


$

24,855


$

22,204




$

41,306


$

73,048



Standex International Corporation

Reconciliation of GAAP to Non-GAAP Financial Measures

(unaudited)























Three Months Ended





Year Ended



Adjusted earnings per share from continuing operations



June 30,





June 30,





2025



2024


%
Change



2025



2024


% Change



















Diluted earnings per share from net income attributable to Standex, as reported


$

1.23


$

1.66


-25.9%


$

4.64


$

6.18


-24.9%



















Adjustments:


















Restructuring charges



0.20



0.06





0.45



0.53




Acquisition-related costs



0.07



0.02





1.43



0.17




Amortization of acquired intangible assets



0.32



0.13





0.94



0.53




(Gain) loss on sale of business



-



-





-



(0.02)




Foreign currency related (gain) loss on acquisition and divestiture activities



-



-





0.04



0.02




Environmental remediation



-



-





-



0.01




Discrete tax items



0.29



-





(0.45)



0.01




Purchase accounting expenses



0.17



0.02





0.93



0.11



Diluted earnings per share from net income attributable to Standex, as adjusted


$

2.28


$

1.89


20.7%


$

7.98


$

7.54


5.8%

Cision View original content to download multimedia:

SOURCE Standex International Corporation

FAQ

What were Standex's (SXI) key financial results for Q4 FY25?

Standex reported Q4 FY25 sales of $222.0 million (up 23.2% YOY), adjusted operating margin of 20.6% (up 350 bps YOY), and adjusted EPS of $2.28 (up 20.6% YOY).

How much debt did Standex (SXI) pay down in Q4 FY25?

Standex paid down $27 million of debt in Q4 FY25, reducing their net debt to EBITDA ratio to 2.6x.

What is Standex's (SXI) revenue growth outlook for FY26?

Standex expects revenue to grow by over $100 million in FY26, with fast growth market sales projected to grow ~45% and exceed $265 million.

How did Standex's Electronics segment perform in Q4 FY25?

The Electronics segment revenue increased 43.2% to $115.2 million, with adjusted operating margin of 28.5% and a book-to-bill ratio of 1.03.

What is Standex's (SXI) dividend payment for Q4 FY25?

Standex declared a quarterly cash dividend of $0.32 per share, representing a 6.7% year-over-year increase, payable August 22, 2025.
Standex Intl

NYSE:SXI

SXI Rankings

SXI Latest News

SXI Latest SEC Filings

SXI Stock Data

1.99B
11.88M
1.66%
97.19%
2.04%
Specialty Industrial Machinery
Refrigeration & Service Industry Machinery
United States
SALEM